Search
for
Sort by
Research 721–750 of 1000+
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Propecia-induced spermatogenic failure: a report of two cases
- Intraoperative floppy-iris syndrome and finasteride intake
- The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia
- Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
- Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants
- Inhibition of Human Steroid 5β-Reductase (AKR1D1) by Finasteride and Structure of the Enzyme-Inhibitor Complex
- A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism
- Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride
- A preliminary study of finasteride in Tourette syndrome
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
- Picogram determination of finasteride in human plasma and semen by high-performance liquid chromatography with atmospheric-pressure chemical-ionization tandem mass spectrometry
- Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women
- Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up
- Evaluation of Sexual Function With an International Index of Erectile Function in Subjects Taking Finasteride for Androgenetic Alopecia
- A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia
- An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia
- Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone
- Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia
- Treatment of Tourette’s Syndrome With Finasteride
- Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride